| Literature DB >> 34232117 |
Migle Gabrielaite1, Finn C Nielsen1, Helle K Johansen2,3, Rasmus L Marvig1.
Abstract
Achromobacter spp. are emerging pathogens in patients with cystic fibrosis (CF) and Achromobacter spp. caused infections are associated with more severe disease outcomes and high intrinsic antibiotic resistance. While conventional CF pathogens are studied extensively, little is known about the genetic determinants leading to antibiotic resistance and the genetic adaptation in Achromobacter spp. infections. Here, we analysed 101 Achromobacter spp. genomes from 51 patients with CF isolated during the course of up to 20 years of infection to identify within-host adaptation, mutational signatures and genetic variation associated with increased antibiotic resistance. We found that the same regulatory and inorganic ion transport genes were frequently mutated in persisting clone types within and between Achromobacter species, indicating convergent genetic adaptation. Genome-wide association study of six antibiotic resistance phenotypes revealed the enrichment of associated genes involved in inorganic ion transport, transcription gene enrichment in β-lactams, and energy production and translation gene enrichment in the trimethoprim/sulfonamide group. Overall, we provide insights into the pathogenomics of Achromobacter spp. infections in patients with CF airways. Since emerging pathogens are increasingly recognized as an important healthcare issue, our findings on evolution of antibiotic resistance and genetic adaptation can facilitate better understanding of disease progression and how mutational changes have implications for patients with CF.Entities:
Keywords: Achromobacter; GWAS; cystic fibrosis airway infection; genomic adaptation; host-pathogen interaction; microbial genomics; within-host evolution
Mesh:
Year: 2021 PMID: 34232117 PMCID: PMC8477396 DOI: 10.1099/mgen.0.000582
Source DB: PubMed Journal: Microb Genom ISSN: 2057-5858
Fig. 1.Overview of 101 longitudinally collected spp. isolates from patients with CF.
Fig. 2.spp. genetic differences. (a) Phylogenetic tree based on core genome SNPs of 101 spp. isolates from patients with CF (inner layer of colours: turquoise) and 141 spp. isolates from RefSeq database (inner layer of colours: yellow). Outer layer of colours corresponds to species annotation with suggested corrections; red arrows mark supposedly incorrect species annotation in RefSeq isolates. The phylogenetic tree can be accessed on Microreact webserver [66]. (b) The aggregated pan-genome of 61 spp. lineages containing gene presence, absence, and gene variability (i.e. gene is present in some isolates while absent in other isolates within the lineage) information.
Pan-genome size, number of core, accessory and unique genes for isolates from each species
|
Species |
No. of bacterial isolates |
Pan-genome size |
Core genes |
Accessory genes |
Unique genes |
|---|---|---|---|---|---|
|
|
29 |
7070 |
5130 |
1940 |
976 |
|
|
18 |
9900 |
4799 |
5101 |
1124 |
|
|
52 |
14833 |
4225 |
10608 |
3162 |
Fig. 3.Overview of genetic determinants related to virulence and antibiotic resistance, and pathoadaptive genes. (a) Antibiotic resistance and virulence gene orthologue distribution among lineages. (b) Venn diagram of the most frequently mutated genes and their overlap between the three species. (c) Candidate pathoadaptive gene mutation distribution by lineage.
Fig. 4.COG annotations of (a) three spp. reference genomes and most frequently mutated genes, and (b) frequently associated with antibiotic resistance unitigs. Red boxes mark COGs, which are ≥2x enriched in GWAS compared to reference genomes.
Seven most frequently mutated genes and their function
|
RefSeq ID (Locus tag) |
No. of species |
No. of lineages |
Product |
Function |
|---|---|---|---|---|
|
WP_006389199.1 (AT699_RS06735) |
3 |
10 |
DNA-binding transcriptional regulator AxyZ |
Antibiotic resistance |
|
WP_006227290.1 (AT699_RS01870) |
2 |
5 |
NAD(P)/FAD-dependent oxidoreductase |
Metabolic pathways |
|
WP_013391523.1 (AT699_RS03490) |
2 |
10 |
Penicillin-binding protein 2 |
Antibiotic resistance |
|
WP_006392856.1 (AT699_RS03490) |
2 |
9 |
ABC transporter substrate-binding protein |
Transport |
|
WP_006394390.1 (AT699_RS11865) |
2 |
9 |
multidrug efflux RND transporter permease |
Antibiotic resistance |
|
WP_006387572.1 (AT699_RS22580) |
2 |
8 |
Signal transduction histidine kinase |
Two-component signalling |
|
WP_006221301.1 (AT699_RS25090) |
2 |
10 |
TonB-dependent hemin, ferrichrome receptor |
Transport |